ReNeuron Group Plc has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to conduct a first-in-man trial of a stem cell therapy to treat stroke. ---Subscribe to MedNous to access this article--- Regenerative Medicine
